Automatic Detection of Left Ventricular Dilatation and Hypertrophy from Electrocardiograms Using Deep Learning.

Journal: International heart journal
PMID:

Abstract

Left ventricular dilatation (LVD) and left ventricular hypertrophy (LVH) are risk factors for heart failure, and their detection improves heart failure screening. This study aimed to investigate the ability of deep learning to detect LVD and LVH from a 12-lead electrocardiogram (ECG). Using ECG and echocardiographic data, we developed deep learning and machine learning models to detect LVD and LVH. We also examined conventional ECG criteria for the diagnosis of LVH. We calculated the area under the receiver operating characteristic (AUROC) curve, sensitivity, specificity, and accuracy of each model and compared the performance of the models. We analyzed data for 18,954 patients (mean age (standard deviation): 64.2 (16.5) years, men: 56.7%). For the detection of LVD, the value (95% confidence interval) of the AUROC was 0.810 (0.801-0.819) for the deep learning model, and this was significantly higher than that of the logistic regression and random forest methods (P < 0.001). The AUROCs for the logistic regression and random forest methods (machine learning models) were 0.770 (0.761-0.779) and 0.757 (0.747-0.767), respectively. For the detection of LVH, the AUROC was 0.784 (0.777-0.791) for the deep learning model, and this was significantly higher than that of the logistic regression and random forest methods and conventional ECG criteria (P < 0.001). The AUROCs for the logistic regression and random forest methods were 0.758 (0.751-0.765) and 0.716 (0.708-0.724), respectively. This study suggests that deep learning is a useful method to detect LVD and LVH from 12-lead ECGs.

Authors

  • Takahiro Kokubo
    School of Public Health, Graduate School of Medicine, The University of Tokyo.
  • Satoshi Kodera
    Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo.
  • Shinnosuke Sawano
    Department of Cardiovascular Medicine, The University of Tokyo.
  • Susumu Katsushika
    Department of Cardiovascular Medicine, The University of Tokyo.
  • Mitsuhiko Nakamoto
    Department of Cardiovascular Medicine, The University of Tokyo.
  • Hirotoshi Takeuchi
    Department of Cardiovascular Medicine, The University of Tokyo Hospital.
  • Nisei Kimura
    Department of Technology Management for Innovation, The University of Tokyo.
  • Hiroki Shinohara
    Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo.
  • Ryo Matsuoka
    Department of Cardiovascular Medicine, The University of Tokyo.
  • Koki Nakanishi
    Department of Cardiovascular Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.
  • Tomoko Nakao
    Department of Cardiovascular Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.
  • Yasutomi Higashikuni
    Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo.
  • Norifumi Takeda
    Department of Cardiovascular Medicine, The University of Tokyo.
  • Katsuhito Fujiu
    Department of Cardiovascular Medicine, The University of Tokyo.
  • Masao Daimon
    Department of Cardiovascular Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.
  • Hiroshi Akazawa
    Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo.
  • Hiroyuki Morita
    Department of Cardiovascular Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.
  • Yutaka Matsuyama
    School of Public Health, Graduate School of Medicine, The University of Tokyo.
  • Issei Komuro
    Department of Cardiovascular Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.